Meillan N - Search Results

1

Long-Term Outcomes in Head and Neck Paragangliomas Managed with Intensity-Modulated Radiotherapy.

Rougier G, Rochand A, Bourdais R, Meillan N, Tankere F, Herman P, Riet F, Mazeron JJ, Burnichon N, Lussey-Lepoutre C, Jacob J, Simon JM, Maingon P, Feuvret L. Rougier G, et al. Among authors: meillan n. Laryngoscope. 2023 Mar;133(3):607-614. doi: 10.1002/lary.30226. Epub 2022 May 31. Laryngoscope. 2023. PMID: 35638238

2

Mismatch Repair System Deficiency Is Associated With Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.

Meillan N, Vernerey D, Lefèvre JH, Manceau G, Svrcek M, Augustin J, Fléjou JF, Lascols O, Simon JM, Cohen R, Maingon P, Bachet JB, Huguet F. Meillan N, et al. Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):824-833. doi: 10.1016/j.ijrobp.2019.07.057. Epub 2019 Aug 9. Int J Radiat Oncol Biol Phys. 2019. PMID: 31404579

3

Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma.

Tang E, Lahmi L, Meillan N, Pietta G, Albert S, Maingon P. Tang E, et al. Among authors: meillan n. Curr Oncol Rep. 2019 Nov 14;21(11):102. doi: 10.1007/s11912-019-0856-5. Curr Oncol Rep. 2019. PMID: 31728650 Review.

4

Optic nerve motion and gaze direction: Their impact on intraorbital tumor radiotherapy.

Mesny E, Jacob J, Culot F, Calugaru V, Jenny C, Fonti B, Bourdais R, Courtault-Deslandes F, Boulle G, Meillan N, Simon JM, Maingon P, Feuvret L. Mesny E, et al. Among authors: meillan n. Cancer Radiother. 2022 Sep;26(5):678-683. doi: 10.1016/j.canrad.2021.12.003. Epub 2022 Feb 25. Cancer Radiother. 2022. PMID: 35227595

5

[Towards an integrated approach to cardiovascular toxicities related to the treatments of breast cancer].

Tanz R, Magne N, Annede P, Mery B, Jacob J, Bauduceau O, Trone JC, Guichard JB, Meillan N, Kirova Y, Vedrine L, Chargari C. Tanz R, et al. Among authors: meillan n. Bull Cancer. 2014 Jul-Aug;101(7-8):730-40. doi: 10.1684/bdc.2014.1926. Bull Cancer. 2014. PMID: 25091656 Review. French.

6

Rectal cancer radiotherapy.

Vendrely V, Rivin Del Campo E, Modesto A, Jolnerowski M, Meillan N, Chiavassa S, Serre AA, Gérard JP, Créhanges G, Huguet F, Lemanski C, Peiffert D. Vendrely V, et al. Among authors: meillan n. Cancer Radiother. 2022 Feb-Apr;26(1-2):272-278. doi: 10.1016/j.canrad.2021.11.002. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34953708

7

[Adjuvant treatments for endometrial cancer].

Meillan N. Meillan N. Rev Prat. 2022 Sep;72(7):743-746. Rev Prat. 2022. PMID: 36511961 French.

8

[Follow-up after radiotherapy of anal canal carcinoma].

Meillan N, Huguet F, Peiffert D. Meillan N, et al. Cancer Radiother. 2015 Oct;19(6-7):610-5. doi: 10.1016/j.canrad.2015.06.011. Epub 2015 Aug 29. Cancer Radiother. 2015. PMID: 26323891 French.

9

[No title available]

[No authors listed] [No authors listed] PMID: 33518239

10

Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors.

Meillan N, Orthuon A, Chauchat P, Atlani D, Bouche O, Chaulin B, David C, Deberne M, Debrigode C, Kao W, Keller A, Laharie H, Lamezec B, Lemanski C, Magné N, Mahé MA, Mere P, Moureau-Zabotto L, Peiffert D, Pointreau Y, Quéro L, Racadot S, Roca S, Sargos P, Servagi S, Tang E, Vendrely V, Doyen J, Huguet F. Meillan N, et al. Radiother Oncol. 2021 Aug;161:198-204. doi: 10.1016/j.radonc.2021.06.006. Epub 2021 Jun 16. Radiother Oncol. 2021. PMID: 34144078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page